| IPO Company Profile © ipodata.com |
| Message Board | SEC Filings | Peer IPO Companies |
| Americal Medical Labs, Inc. |
| 14225 Newbrook Drive, Chantilly, VA 20153 * (703) 802-6900 |
| Business Description | The company is a leading national provider of esoteric laboratory testing services. Esoteric tests are clinical laboratory tests that are more complex and typically priced higher than routine tests. The company markets its esoteric testing services to hospitals and independent clinical laboratories nationwide |
|
Filing Information Not yet | |||
| To Trade As | AMLS (NASNTL) | Industry | Service (SIC 8071) |
| Type of Stock Offered | Common Shares | Filing Date | 9/29/00 |
| Domestic Shares Filed | 0 | Filing Price | - - |
| Foreign Shares Filed | 0 | Offering Amount | $100,000,000 |
| Company Shares | 0 | Est. Expenses | - - |
| Selling Shrhldrs Shares | 0 | Post-IPO Shares | - - |
| Primary Underwriting Group | ||
| Underwriter Name | Participation | Underwriter Phone |
| CS First Boston | Lead Manager | (212) 325-2000 |
| Banc of America Securities LLC | Co-manager | (415) 627-2100 |
| First Union Capital Markets Corp. | Co-manager | (804) 649-2311 |
| Income Statement and Cash Flow Summary | |||||||
| Prior Audited Income |
Latest Unaudited Income | ||||||
| Full Year Audited Figures | 6 Months Ending | ||||||
| Figures in U.S. millions except per share data | 12/31/98 | 12/31/99 | 6/30/99 | 6/30/00 | |||
| Revenues | - | - | - | 102.729 | 143.436 | 58.609 | 110.094 |
| Income from Oper. | - | - | - | 7.540 | 8.991 | 4.646 | 9.066 |
| Net Income | - | - | - | 3.959 | 1.236 | 3.012 | 0.507 |
| E.P.S | - | - | - | - | - | - | - |
| Revenue Growth (%) | - | - | - | 39.626 | 87.84 | ||
| Net Income Growth (%) | - | - | - | -68.78 | -83.17 | ||
| Oper. Profit Margin (%) | - | - | - | 7.34 | 6.27 | 8.23 | 7.93 |
| Net Profit Margin (%) | - | - | - | 3.85 | 0.86 | 0.46 | 5.14 |
| Cash Flow - Oper. | 1.71 | - | - | ||||
| Cash Flow - Inv. | -88.43 | - | - | ||||
| Cash Flow - Fin. | 87.59 | - | - | ||||
| Balance Sheet Summary and Financial Ratios | |||||
| Balance sheet as of: 6/30/00 | Financial Ratios | ||||
| Total Assets | 202.35 | Current Assets | - | Current Ratio | - |
| Total Liab. | 191.14 | Current Liab. | - | Debt Ratio | 94.46% |
| Total Equity | 11.21 | Working Cap. | - | Debt to Equity Ratio | 17.05 |
| Cash | 1.01 | Return on Assets | 0.25% | ||
| Use Of Proceeds |
The proceeds from the proposed offering will be used to repay indebtedness. |
| Legal Counsel Registrar Auditor | |
| Issuer's Law Firm | Kirkland & Ellis |
| Bank's Law Firm | Latham & Watkins |
| Registrar/Transfer Agent | American Stock Transfer & Trust Co |
| Auditor | KPMG LLC |
| Send us feedback if you would like to request that we hyperlink a firm on this page | |
| Principal Shareholders | ||
| Name of Shareholder | % Owned Before | % Owned After |
| Golder, Thoma, Cressey, Rauner Fund V, L.P. | 64.50 | |
| Note: represents ownership of 5% or more prior to the offering. | ||